- Home
- ADTX vs OMH Comparison
ADTX vs OMH Comparison
Compare ADTX & OMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADTX
- OMH
- Stock Information
- Founded
- ADTX 2017
- OMH 2015
- Country
- ADTX United States
- OMH Singapore
- Employees
- ADTX N/A
- OMH N/A
- Industry
- ADTX Biotechnology: Pharmaceutical Preparations
- OMH Real Estate
- Sector
- ADTX Health Care
- OMH Finance
- Exchange
- ADTX Nasdaq
- OMH Nasdaq
- Market Cap
- ADTX 5.3M
- OMH N/A
- IPO Year
- ADTX 2020
- OMH 2023
- Fundamental
- Price
- ADTX $5.00
- OMH $2.23
- Analyst Decision
- ADTX
- OMH Strong Buy
- Analyst Count
- ADTX 0
- OMH 1
- Target Price
- ADTX N/A
- OMH $15.00
- AVG Volume (30 Days)
- ADTX 8.1M
- OMH 17.0K
- Earning Date
- ADTX 05-19-2025
- OMH 01-01-0001
- Dividend Yield
- ADTX N/A
- OMH N/A
- EPS Growth
- ADTX N/A
- OMH N/A
- EPS
- ADTX N/A
- OMH N/A
- Revenue
- ADTX $133,985.00
- OMH $5,390,607.00
- Revenue This Year
- ADTX $95.61
- OMH $111.47
- Revenue Next Year
- ADTX $1,584.79
- OMH $32.08
- P/E Ratio
- ADTX N/A
- OMH N/A
- Revenue Growth
- ADTX N/A
- OMH 25.77
- 52 Week Low
- ADTX $4.11
- OMH $0.25
- 52 Week High
- ADTX $35,000.00
- OMH $2.70
- Technical
- Relative Strength Index (RSI)
- ADTX 33.28
- OMH 63.38
- Support Level
- ADTX $4.17
- OMH $2.12
- Resistance Level
- ADTX $7.69
- OMH $2.31
- Average True Range (ATR)
- ADTX 1.92
- OMH 0.23
- MACD
- ADTX 0.36
- OMH -0.07
- Stochastic Oscillator
- ADTX 10.10
- OMH 25.34
About ADTX Aditxt Inc.
Aditxt Inc is a life sciences company that develops, builds, and grows innovations with a focus on monitoring and modulating the immune system. It develops products designed to induce tolerance to transplanted organs. Its portfolio consists of two programs Adimune and AditxtScore. It firm's immunosuppressive (anti-rejection) drugs have made possible life-saving organ transplantation procedures and blocking of unwanted immune responses in autoimmune diseases. It is also developing a technology called Apoptotic DNA Immunotherapy (ADi) ADI-100, which utilizes a novel approach that mimics the way bodies naturally induce tolerance to tissues.